Vimarsana
Biggest News Aggregation in the World

Page 6 - Assertio Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Assertio Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Assertio Therapeutics Today - Breaking & Trending Today

Levi & Korsinsky, LLP Announces Proposed Settlement of the Depomed (nka Assertio Therapeutics) Securities Litigation - Vimarsana News

Levi & Korsinsky, LLP Announces Proposed Settlement of the Depomed (nka Assertio Therapeutics) Securities Litigation

WASHINGTON, April 25, 2022 /PRNewswire/ -- UNITED STATES DISTRICT COURTNORTHERN DISTRICT OF CALIFORNIAINCHEN HUANG, Individually and on Behalf of ...

Collegium diversifies with $604M BDSI buyout, adding pain & migraine meds - Vimarsana News

Collegium diversifies with $604M BDSI buyout, adding pain & migraine meds

Collegium Pharmaceutical’s acquisition of BioDelivery Sciences International brings a pain drug that’s administered in a different way than its current lineup of medicines. The deal also gives Collegium a way to break into the neurology market.

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Ready to Use Diclofenac Stick Packs - Vimarsana News

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Ready to Use Diclofenac Stick Packs

EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Patent Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application

Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowa - Vimarsana News

Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowa

RELIEF THERAPEUTICS Holding AG / Key word(s): Patent24-Jan-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key...

EQS-Adhoc: Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Ready to Use Diclofenac Stick Packs - Vimarsana News

EQS-Adhoc: Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Ready to Use Diclofenac Stick Packs

EQS-Ad-hoc: Relief Therapeutics Holding AG / Key word(s): Patent Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Re...